STOCK TITAN

MacroGenics (MGNX): Millennium group discloses 3.7% beneficial stake in amended 13G

(Neutral)
(Neutral)
Form Type
SCHEDULE 13G/A

Rhea-AI Filing Summary

MacroGenics, Inc. received an amended Schedule 13G indicating that Millennium Management LLC, Millennium Group Management LLC and Israel A. Englander collectively report beneficial ownership of 2,374,296 shares of MacroGenics common stock. This represents 3.7% of the outstanding common stock.

The reporting persons disclose no sole voting or dispositive power and shared voting and shared dispositive power over 2,374,296 shares. They state that the securities are held by entities subject to their voting control or investment discretion and note that the filing should not itself be construed as an admission of beneficial ownership. They also confirm that they now own 5% or less of this class of securities.

Positive

  • None.

Negative

  • None.
Shares beneficially owned 2,374,296 shares Beneficially owned by Millennium Management LLC, Millennium Group Management LLC and Israel A. Englander
Percent of class 3.7% Percentage of MacroGenics common stock beneficially owned by the reporting persons
Shared voting power 2,374,296 shares Shares over which the reporting persons have shared power to vote or direct the vote
Shared dispositive power 2,374,296 shares Shares over which the reporting persons have shared power to dispose or direct disposition
Sole voting power 0 shares Shares over which the reporting persons have sole power to vote or direct the vote
Sole dispositive power 0 shares Shares over which the reporting persons have sole power to dispose or direct disposition
beneficially owned financial
"Amount beneficially owned: See response to Item 9 on each cover page."
Beneficially owned describes securities or assets where a person has the economic rights and control—such as the right to receive dividends and to direct voting—even if legal title is held in another name. Think of it like having the keys and using a car that’s registered to someone else: you get the benefits and make decisions. Investors care because beneficial ownership reveals who truly controls value and voting power, affecting corporate decisions and takeover dynamics.
Shared Voting Power financial
"Shared Voting Power 2,374,296.00"
Shared voting power occurs when two or more parties jointly have the right to vote or decide how a block of company shares is cast, like co-owners who must agree before moving a piece of furniture. Investors care because who controls voting rights affects board elections, major corporate decisions and takeover outcomes, and shared control can alter regulatory disclosures and the practical influence any holder has over a company’s direction and value.
Shared Dispositive Power financial
"Shared Dispositive Power 2,374,296.00"
dispositive power financial
"Sole Dispositive Power 0.00 8 | Shared Dispositive Power 2,374,296.00"
Dispositive power is the authority to decide the final outcome of an asset, legal claim, contract, or corporate action — in effect the power to dispose of or resolve something. For investors it matters because whoever holds that authority can determine who gets paid, who controls an asset or vote, and how risks and returns are allocated; think of it like holding the key that lets you lock in the winner or loser in a deal.
Joint Filing Agreement regulatory
"Exhibit I: Joint Filing Agreement, dated as of July 17, 2026"

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google
Learn about SEC filing dates

FAQ

What ownership stake in MacroGenics (MGNX) does Millennium Management report in this Schedule 13G/A?

Millennium Management and related filers report beneficial ownership of 2,374,296 MacroGenics shares, representing 3.7% of the common stock. All of these shares are reported with shared voting and shared dispositive power.

Does the Millennium group still hold more than 5% of MacroGenics (MGNX) common stock?

No. The filing states ownership of 5 percent or less of MacroGenics’ common stock. Their reported beneficial ownership is 3.7%, based on 2,374,296 shares held with shared voting and dispositive power.

How much voting power over MacroGenics (MGNX) shares does Millennium report?

The reporting persons disclose 0 shares with sole voting power and 2,374,296 shares with shared voting power. They similarly report no sole dispositive power and shared dispositive power over the same 2,374,296 shares.

Who are the reporting persons in this MacroGenics (MGNX) Schedule 13G/A amendment?

The reporting persons are Millennium Management LLC, Millennium Group Management LLC, and Israel A. Englander. They file jointly pursuant to a Joint Filing Agreement dated July 17, 2026, covering their reported MacroGenics holdings.

What disclaimer about beneficial ownership do the MacroGenics (MGNX) reporting persons include?

They explain that the shares are held by entities subject to their control but state the disclosure should not be construed as an admission of beneficial ownership by Millennium Management LLC, Millennium Group Management LLC, or Israel A. Englander.





556099109

(CUSIP Number)
06/30/2026

(Date of Event Which Requires Filing of this Statement)


Check the appropriate box to designate the rule pursuant to which this Schedule is filed:
Rule 13d-1(b)
Rule 13d-1(c)
Rule 13d-1(d)




schemaVersion:


SCHEDULE 13G





SCHEDULE 13G





SCHEDULE 13G





SCHEDULE 13G



Millennium Management LLC
Signature:/s/ Gil Raviv
Name/Title:Gil Raviv, Global General Counsel
Date:07/17/2026
Millennium Group Management LLC
Signature:/s/ Gil Raviv
Name/Title:Gil Raviv, Global General Counsel
Date:07/17/2026
Israel A. Englander
Signature:/s/ Israel A. Englander
Name/Title:Israel A. Englander
Date:07/17/2026
Exhibit Information

Exhibit I: Joint Filing Agreement, dated as of July 17, 2026, by and among Millennium Management LLC, Millennium Group Management LLC and Israel A. Englander.